Will DGCI ban on drug ingredients from China hurt the Pharma industry?

The ban on the import of APIs from China may lead to possible shortages of antibiotics, and anti-
diabetes, anti-psychotic and antacid drugs, say pharma lobby groups
Subscribe Now For Latest Updates- https://tinyurl.com/lbw8nze